idarubicin has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia, L; Kelsey, SM; Liu, FT; Newland, AC | 1 |
| Ciarcia, R; Crispino, L; D'Andrilli, G; de Matteis, A; Florio, S; Giordano, A; Kumar, C; Pacilio, C; Pagnini, U; Vacca, G | 1 |
2 other study(ies) available for idarubicin and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Generation of reactive oxygen species is not involved in idarubicin-induced apoptosis in human leukaemic cells.
Topics: Amino Acid Chloromethyl Ketones; Antibiotics, Antineoplastic; Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Death; Cell Line; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Potentials; Mitochondria; Reactive Oxygen Species | 2001 |
MPA increases idarubicin-induced apoptosis in chronic lymphatic leukaemia cells via caspase-3.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase Inhibitors; Caspases; Dogs; Drug Synergism; Enzyme Inhibitors; Fluorometry; Idarubicin; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Medroxyprogesterone Acetate; Nucleosomes; Propidium; Tumor Cells, Cultured | 2003 |